Diagnosing Cancer-Associated Ischemic Stroke: A Systematic Review of Hematological Biomarkers.

Increased D-dimer seems associated with cancer-related ischemic stroke. CRP may also be a candidate as a cancer-associated stroke biomarker, but this requires further verification. Fibrinogen and the more specific cancer biomarkers have not yet been proven helpful for detecting cancer-related strokes.